Rural Health
Resources by Topic: Substance use and misuse
Can a Participant-Referred "Study Buddy" Increase Retention of Rural People Who Use Drugs in Research? A Multi-Site, Randomized Trial
Presents a study exploring the efficacy of an intervention aiming to increase retention of rural people who use drugs (PWUD) participating in randomized trials. Highlights an intervention involving participant recruitment of a support person, or "study buddy", to aid in the their continued participation in the study. Compares the efficacy of this intervention with standard retention practices.
Author(s): April M. Young, Kathryn E. Lancaster, Miriam R. Elman, et al.
Citation: Addiction, 121(4), 894-907
Date: 04/2026
view details
Presents a study exploring the efficacy of an intervention aiming to increase retention of rural people who use drugs (PWUD) participating in randomized trials. Highlights an intervention involving participant recruitment of a support person, or "study buddy", to aid in the their continued participation in the study. Compares the efficacy of this intervention with standard retention practices.
Author(s): April M. Young, Kathryn E. Lancaster, Miriam R. Elman, et al.
Citation: Addiction, 121(4), 894-907
Date: 04/2026
view details
Cigarette and Electronic Cigarette Use Among Adults by Urbanization Level: United States, 2024
Offers 2024 data showing the percentage of adults who use cigarettes and electronic cigarettes by 4 levels of urbanization. Includes a break down by age ranges.
Date: 03/2026
Sponsoring organization: National Center for Health Statistics
view details
Offers 2024 data showing the percentage of adults who use cigarettes and electronic cigarettes by 4 levels of urbanization. Includes a break down by age ranges.
Date: 03/2026
Sponsoring organization: National Center for Health Statistics
view details
Brief Prescribing Support and Buprenorphine Adoption in Rural Primary Care: A Cluster Randomized Clinical Trial
Explores the efficacy of a brief support program on rural primary care providers willingness to prescribe buprenorphine for opioid use disorder (OUD). Breaks down the support program modules aimed at educating providers about buprenorphine-based treatment and prescribing practices. Highlights post-intervention changes in prescribing and treatment outcomes.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, Daniel Brook, et al.
Citation: JAMA Network Open, 9(3), e263050
Date: 03/2026
view details
Explores the efficacy of a brief support program on rural primary care providers willingness to prescribe buprenorphine for opioid use disorder (OUD). Breaks down the support program modules aimed at educating providers about buprenorphine-based treatment and prescribing practices. Highlights post-intervention changes in prescribing and treatment outcomes.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, Daniel Brook, et al.
Citation: JAMA Network Open, 9(3), e263050
Date: 03/2026
view details
Resilience to Stigma in Medical, Social, and Employment Contexts among People Who Inject Drugs in Rural Ohio: Adapting the 10-Item Connor-Davidson Resilience Scale
Explores the role stigma related to drug use and HIV plays in the lives of people who inject drugs (PWID) and aims to build resilience in medical, social, and employment contexts for PWID in rural Appalachian Ohio. Presents results from a series of interviews and a qualitative survey placing participants on the Connor-Davidson Resilience Scale.
Author(s): Madison N. Enderle, Rebecca H. Neiberg, Stacy M. Endres-Dighe, et al.
Citation: AIDS and Behavior, 30, 894-906
Date: 03/2026
view details
Explores the role stigma related to drug use and HIV plays in the lives of people who inject drugs (PWID) and aims to build resilience in medical, social, and employment contexts for PWID in rural Appalachian Ohio. Presents results from a series of interviews and a qualitative survey placing participants on the Connor-Davidson Resilience Scale.
Author(s): Madison N. Enderle, Rebecca H. Neiberg, Stacy M. Endres-Dighe, et al.
Citation: AIDS and Behavior, 30, 894-906
Date: 03/2026
view details
Comparing the Care and Distance Traveled by Rural and Urban Medicaid Beneficiaries With Opioid Use Disorder
Results of a study describing the treatment for rural and urban Medicaid beneficiaries with opioid use disorder in 2019. Features demographics and statistics on number of visits and travel time and distance, with breakdowns by 5 levels of population density.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Lisa A. Garberson, Janessa M. Graves
Date: 03/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Results of a study describing the treatment for rural and urban Medicaid beneficiaries with opioid use disorder in 2019. Features demographics and statistics on number of visits and travel time and distance, with breakdowns by 5 levels of population density.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Lisa A. Garberson, Janessa M. Graves
Date: 03/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
State of North Carolina's Mental Health and Substance Use Services Workforce: Need, Supply, and Distribution Landscape Assessment
Provides an overview on need, supply, and distribution of behavioral health professionals in North Carolina. Includes county-level maps and data on workforce and behavioral health issues.
Author(s): Brianna Lombardi, Jennifer Headley, Monica P. Jimenez, et al.
Date: 03/2026
Sponsoring organization: The Cecil G. Sheps Center for Health Services Research
view details
Provides an overview on need, supply, and distribution of behavioral health professionals in North Carolina. Includes county-level maps and data on workforce and behavioral health issues.
Author(s): Brianna Lombardi, Jennifer Headley, Monica P. Jimenez, et al.
Date: 03/2026
Sponsoring organization: The Cecil G. Sheps Center for Health Services Research
view details
Empowering Rural Communities: Overcoming Barriers to Substance Use Treatment
Webinar recording discusses the ways rural communities can overcome barriers to substance use disorder (SUD) treatment and uptake. Explores substance use data for rural communities and outlines common barriers, such as travel times and distance to care, provider shortages, and concerns about stigma and patient confidentiality. Highlights strategies for rural communities to leverage their community bonds and faith communities to address SUD, and details models for expanding treatment and patient support in rural areas.
Additional links: Webinar Slides
Date: 02/2026
Sponsoring organization: Addiction Technology Transfer Center Network
view details
Webinar recording discusses the ways rural communities can overcome barriers to substance use disorder (SUD) treatment and uptake. Explores substance use data for rural communities and outlines common barriers, such as travel times and distance to care, provider shortages, and concerns about stigma and patient confidentiality. Highlights strategies for rural communities to leverage their community bonds and faith communities to address SUD, and details models for expanding treatment and patient support in rural areas.
Additional links: Webinar Slides
Date: 02/2026
Sponsoring organization: Addiction Technology Transfer Center Network
view details
Methamphetamine Use, Mental Health Comorbidities, and Treatment in Rural and Urban Areas, 2016-2019
Examines the prevalence of methamphetamine use by level of rurality and U.S. region, with data on methamphetamine use and mental illness, suicide and suicidal ideation, concurrent alcohol use, treatment for methamphetamine use disorder, method of use, and other relating to methamphetamine use prevalence and associated risks.
Author(s): Signe E. Burchim, Lisa A. Garberson, Sara C. Woolcock, et al.
Date: 02/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
Examines the prevalence of methamphetamine use by level of rurality and U.S. region, with data on methamphetamine use and mental illness, suicide and suicidal ideation, concurrent alcohol use, treatment for methamphetamine use disorder, method of use, and other relating to methamphetamine use prevalence and associated risks.
Author(s): Signe E. Burchim, Lisa A. Garberson, Sara C. Woolcock, et al.
Date: 02/2026
Sponsoring organization: WWAMI Rural Health Research Center
view details
The Economic Burden of Mental Health and Substance Use Disorders: The United States and the Heartland Region
Examines how mental health and substance use disorders (MH/SUDs) affect healthcare spending and lost productivity in the heartland region of the United States, using 2016-2023 AHRQ MEPS data from seven selected states. See page 20 for discussion of rurality as a factor influencing MH/SUD treatment access.
Author(s): Alexandra F. Kritikos, Meg Hefferon, Devi Chelluri, MacKenzie L. Hughes
Date: 02/2026
Sponsoring organization: NORC at the University of Chicago
view details
Examines how mental health and substance use disorders (MH/SUDs) affect healthcare spending and lost productivity in the heartland region of the United States, using 2016-2023 AHRQ MEPS data from seven selected states. See page 20 for discussion of rurality as a factor influencing MH/SUD treatment access.
Author(s): Alexandra F. Kritikos, Meg Hefferon, Devi Chelluri, MacKenzie L. Hughes
Date: 02/2026
Sponsoring organization: NORC at the University of Chicago
view details
Clinical and Demographic Characteristics of Participants in a Hepatitis C Treatment Trial in Rural Kentucky: How Policies Around Treatment Access May Impact Elimination Efforts in the United States
Examines characteristics and drug use patterns of the participants in the Kentucky Viral Hepatitis C Treatment (KeY Treat) trial, which focuses on improving access to direct acting antiviral (DAA) drugs to treat the hepatitis C virus (HCV). Discuses Medicaid policy related to DAA treatment of HCV in a rural, Appalachian community in Kentucky.
Author(s): Jennifer R. Havens, Brittney D. Williams, Takako Schaninger, et al.
Citation: Journal of Rural Health, 42(1), e70128
Date: 02/2026
view details
Examines characteristics and drug use patterns of the participants in the Kentucky Viral Hepatitis C Treatment (KeY Treat) trial, which focuses on improving access to direct acting antiviral (DAA) drugs to treat the hepatitis C virus (HCV). Discuses Medicaid policy related to DAA treatment of HCV in a rural, Appalachian community in Kentucky.
Author(s): Jennifer R. Havens, Brittney D. Williams, Takako Schaninger, et al.
Citation: Journal of Rural Health, 42(1), e70128
Date: 02/2026
view details
